|
|
Article: Final Medicare Decision Provides Maximum Reimbursement to Hospitals for CardioWest temporary Total Artificial Heart.
- Article from:
- Business Wire
- Article date:
- May 6, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CMS Reverses 1986 National Non-Coverage Decision for the Artificial Heart
TUCSON, Ariz. -- On May 1, the Centers for Medicare and Medicaid Services (CMS) issued its final National Coverage Decision (NCD) to reimburse the CardioWest[TM] temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.
"Our decision revises a long-standing non-coverage policy and allows beneficiary access to this advanced technology," said CMS Acting Administrator Kerry Weems. "Our decision also encourages the completion of FDA post-approval studies."
"This final decision makes the CardioWest artificial heart available to nearly all ...